Comparative nephrotoxicity of some antitumour-active platinum and ruthenium complexes in rats

Journal of Applied Toxicology

Volumn 18, Issue 2, 1998, Pages 93-101

  Kersten, Lothar ^a   Bräunlich, Helmut ^a   Keppler, Bernhard K ^b   Gliesing, Christiane ^a   Wendelin, Matthias ^a   Westphal, Jens ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Nephrotoxicity; Platinum(II) complexes; Rats; Ruthenium(III) complexes

Indexed keywords

CISPLATIN; PLATINUM; PLATINUM DERIVATIVE; RUTHENIUM;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; FEMALE; KIDNEY FUNCTION; LIPID PEROXIDATION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; KIDNEY; LIPID PEROXIDATION; PLATINUM COMPOUNDS; PROTEINURIA; RATS; RATS, WISTAR; RUTHENIUM COMPOUNDS;

EID: 0031971967     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199803/04)18:2<93::AID-JAT472>3.0.CO;2-W     Document Type: Article

References (42)

1. K. B. Meyer and N. E. Madias, Cisplatin nephrotoxicity. Miner. Electrolyte Metab. 20, 201-213 (1994).
2. G. Daugaard and U. Abildgaard, Cisplatin nephrotoxicity. Cancer Chemother. Pharmacol. 25, 1-9 (1989).
3. J. P. Filastre and G. Raguenez-Viotte, Cisplatin nephrotoxicity. Toxicol. Lett. 46, 163-175 (1989).
4. B. K. Keppler, M. R. Berger, T. Kienner and M. E. Heim, Metal complexes as antitumor agents. Adv. Drug Res. 19, 243-310 (1990).
5. G. Sava, S. Pacor, A. Bergamo, M. Cocchietto, G. Mestroni and E. Alessio, Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition. Chem.-Biol. Interact. 95, 109-126 (1995).
6. T Klenner, H. Münch, F. Wingen, D. Schmähl and B. K. Keppler, Therapeutische Effektivität von neuen Cisplatingekoppelten Biphosphonaten beim transplantablen Osteosarkom der Ratte. J. Cancer Res. Clin. Oncol. Suppl. 114, 162 (1988).
7. M. R. Berger, F. T. Garzon, B. K. Keppler and D. Schmähl, Efficacy of new ruthenium complexes against chemically induced autochthonous colorectal carcinoma in rats. Anticancer Res, 9, 761-766 (1989).
8. M. A. Presnov and A. L. Konovalova, Cycloplatam and oxoplatin - the new antitumor platinum compounds of the second generation. Arch. Geschwulstforsch. 58, 43-49 (1988).
9. M. Drees, W. M. Dengler, H. R. Hendriks, L. R. Keltand and H. H. Fiebig, Cycloplatam: a novel platinum compound exhibiting a different spectrum of anti-tumor activity to cisplatin. Eur. J. Cancer 31A, 356-361 (1995).
10. L. Kersten and H. Bräunlich, Biologische Normalwerte bei Wistarratten (Jena) verschiedenen Alters. V. Die renale Wasser- und Elektrolytausscheidung. Z. Versuchstierk. 10, 195-204 (1968).
11. H. Bräunlich, Ch. Fleck, T. Bajanowski and W. Miosge, Dosisabhängigkeit und Altersgang des renalen tubulären Transportes von p-Aminohippursäure (PAH) bei Ratten nach Injektion von Einzeldosen. Pharmazie 38, 483-485 (1983).
12. W. M. Kluwe, Renal function tests as indicators of kidney injury in subacute toxicity studies. Toxicol. Appl. Pharmacol. 57, 414-424 (1981).
13. R. J. Cross and J. V. Taggart, Renal tubular transport: accumulation of p-aminohippurate by rabbit kidney slices. Am. J. Physiol. 161, 181-190 (1950).
14. G. H. Hirsch, Differential effects of nephrotoxic agents on renal transport and metabolism by use of m vitro techniques. Environ. Health Perspect. 15, 89-99 (1976).
15. H. G. Preuss, D. M. Roxe and E. Bourke, Acidotic alterations in oxidative metabolism influencing rat renal slice ammoniagenesis. Life Sci. 41, 1695-1702 (1987).
16. M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
17. A. C. Bratton and E. K. Marshall, A new coupling component for sulfonamide determination. J. Biol. Chem. 128, 537-550 (1939).
18. G. Ellman and H. Lysko, A precise method for the determination of whole blood and plasma sulfhydryl groups. Anal. Biochem. 93, 98-101 (1979).
19. P. J. Hissin and R. Hilf, A fluorimetric method for determination of oxidized and reduced glutathione in tissue. Anal. Biochem. 74, 214-226 (1976).
20. K. Yagi, Lipid peroxides and human disease. Chem. Phys. Lipids 45, 337-351 (1987).
21. G. Ceriotti and L. Spandrio, A spectrophotometric method for determination of urea. Clin. Chim. Acta 8, 295-299 (1989).
22. R. B. Weiss and M. C. Christian, New cisplatin analogues in development. A review. Drugs 46(3), 360-377 (1993).
23. E. D. Kreuser, B. K. Keppler, W. E. Berdel, A. Piest and E. Thiel, Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines. Sem. Oncol. 19 (Suppl. 3), 73-81 (1992).
24. G. Sava, S. Pacor, F. Bregant and V. Ceschia, Metal complexes of ruthenium: a potential class of selective anticancer drugs. Anticancer Res. 11, 1103-1108 (1991).
25. F. Kratz, N. Mulinacci, L. Messori, I. Bertini and B. K. Keppler, Kinetic, spectroscopic and LPLC studies of the interactions of antitumor ruthenium(III) complexes with serum proteins. In Metal Ions in Biology and Medicine, Vol. 2, ed. by J. Anastassopoulou, Ph. Collery, J. C. Etienne and Th. Theophanides (eds.), pp. 69-74. John Libbey Eurotext, Paris (1992).
26. G. Sava, S. Pacor, F Bregant and V. Ceschia, Metal complexes of ruthenium in cancer chemotherapy. In Metal Ions in Biology and Medicine, ed. by Ph. Collery, L. A. Poirer, M. Manfait and J. C. Etienne (eds.), pp. 471-475. John Libbey Eurotext, Paris (1990).
27. D. Appenroth, K. Winnefeld and H. Bräunlich, Nephrotoxicity and pharmacokinetics of cisplatinum in young and adult rats. Biomed. Biochim. Acta 47, 791-797 (1988).
28. Y. Kameyama, N. Okazaki, M. Nakagawa, H. Koshida, M. Nakamura and M. Gemba, Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices. Toxicol. Lett. 52, 15-24 (1990).
29. G. H. J. Wolfgang, M. A. Dominick, K. M. Walsh, J. D. Hoeschele and D. G. Pegg, Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats. Fundam. Appl. Toxicol. 22, 73-79 (1994).
30. M. E. J. Leibbrandt and G. H. J. Wolfgang, Differential toxicity of cisplatin, carboplatin and Cl-973 correlates with cellular platinum level in rat renal cortical slices. Toxicol. Appl. Pharmacol. 132, 245-252 (1995).
31. R. L. Fisher, J. T. Sanuik, A. J. Gandolfi and K. Brendel, Toxicity of cisplatin and mercuric chloride in human kidney cortical slices. Hum. Exp. Toxicol. 13, 517-523 (1994).
32. K. Nosaka, J. Nakada and H. Endou, Cisplatin-induced alterations in renal structure, ammoniagenesis and gluconeogenesis of rats. Kidney Int. 41, 73-79 (1992).
33. S. J. McGuinness and M. P. Ryan, Mechanism of cisplatin nephrotoxicity in rat renal proximal tubule suspensions. Toxicol. in Vitro 8, 1203-1212 (1994)
34. Ch. Gliesing, Zur Nephrotoxizität von Ruthenium-Komplex-verbindungen mit zytostatischer Wirkung. Dissertation. Medizinische Fakultät der Friedrich-Schiller-Universität, Jena (1990).
35. J. Uozumi, Y. Koikawa, T. Yasumasu, T. Ueda and J. Kumazawa, The effect of methylprednisolone on cisplatin-induced nephrotoxicity in rat renal cortical slices. Res. Exp. Med. 195, 231-235 (1995).
36. S. Frühauf and W J. Zeller, New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells. Cancer Res. 51, 2943-2948 (1991).
37. 2+, and the hydrolysis product of cisplatin in the rat. Cancer Chemother. Pharmacol. 29, 29-32 (1991).
38. M. Gemba, T. Matsushita, C. Fujisawa, T. Yamaguchi and Y. Kameyama, Enhancement by glutathione depletion of cisplatin-induced nephrotoxicity in rats: effect of antioxidant pretreatment. In Nephrotoxicity, Mechanism, Early Diagnosis, and Therapeutic Management, ed by J. H. Bach, N. J. Gregg, M. F. Wilks and L. Delacruz (eds.), pp. 315-320. Marcel Dekker, New York (1991).
39. L. Pendyala, P. J. Creaven, R. Perez, J. R. Zdanowicz and D. Raghavan, Intracellular glutathione and cytotoxicity of platinum complexes. Cancer Chemother. Pharmacol. 36, 271-278 (1995).
40. N. P. E. Vermeulen and G. S. Baldew, The role of lipid peroxidation in the nephrotoxicity of cisplatin. Biochem. Pharmacol. 44, 1193-1199 (1992).
41. E. Bogin, M. Marom and Y. Levi, Changes in serum, liver, and kidneys of cisplatin-treated rats; effects of antioxidants. Eur. J. Clin. Chem. Clin. Biochem. 32, 843-851 (1994).
42. K. Sugihara, S. Nagano and M. Gemba, Effect of cisplatin in vitro production of lipid peroxides in rat kidney cortex. Jpn. J. Pharmacol. 44, 71-76 (1987).